TCD-717

TCD-717 · Traslational Cancer Drugs Pharma, SL

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TCD-717, covering 2014-08-08 to 2014-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors [Phase 1]